Akston Biosciences

Developer of therapeutics for use in autoimmune Type 1 diabetes prevention, ultra-long-acting insulin therapy, and oncology

placeBeverly, Massachusetts, United States calendar_todayFounded 2011 groups61 employees language akstonbio.com

Registered entities

Innovation

17 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,964 times.

YearFilings
20181
20191
20203
20218
20228
20236
20249
20255
20264

Social engagement

Social engagement: 4.7K social following, 7 posts in the last 12 months — around the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%

Recent activity

9 Jun 2026
Event
American College of Veterinary Internal Medicine (ACVIM) Forum 2026
8 May 2026
Event
NAVDF2026
28 Apr 2026
Event
North American Veterinary Dermatology Forum #NAVDF2026
Coming soon